This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignees: Harvard College, The Brigham and Women's Hospital, Inc., The General Hospital Corporation. Active years: 1995-2016.
Company Filing History:
4 out of 3,069 
4 out of 1,422 
1 out of 3,068 
Years Active: 1995-2016
Title: Christine E Seidman: Pioneering Innovations in Cardiomyopathy Research
Introduction
Christine E Seidman is a prominent inventor based in Milton, MA (US), known for her significant contributions to the field of cardiomyopathy research. With a total of 4 patents, she has made remarkable strides in understanding the genetic underpinnings of heart diseases. Her work has paved the way for innovative diagnostic and treatment methods that can potentially save lives.
Latest Patents
Among her latest patents, one notable invention addresses structural mutations in titin that cause dilated cardiomyopathy. This patent provides diagnostic markers and methods for identifying individuals with an increased susceptibility to this condition. The method involves determining if a subject has a mutation in the TTN nucleic acid or titin polypeptide. Additionally, it outlines methods for treating subjects who are at risk of developing dilated cardiomyopathy.
Another significant patent focuses on detecting mutations associated with hypertrophic cardiomyopathy (HC). This invention includes methods for identifying the presence or absence of mutations in DNA that encodes sarcomeric thin filament proteins, such as alpha-tropomyosin or cardiac troponin T. The methods also extend to diagnosing familial HC by detecting mutations in the sarcomeric thin filament proteins, which serve as indicators of the disease.
Career Highlights
Christine has had a distinguished career, working with esteemed institutions such as Harvard College and The Brigham and Women's Hospital, Inc. Her research has not only advanced scientific knowledge but has also contributed to the development of practical applications in the medical field.
Collaborations
Throughout her career, Christine has collaborated with notable colleagues, including Hugh Watkins and Jonathan G Seidman. These partnerships have further enriched her research and expanded the impact of her innovations.
Conclusion
Christine E Seidman stands out as a leading inventor in the realm of cardiomyopathy research. Her innovative patents and collaborative efforts have significantly advanced the understanding and treatment of heart diseases. Her contributions continue to inspire future research and innovation in the medical field.